BCL2 as a Subtype-Specific Prognostic Marker for Breast Cancer

PURPOSE: B-cell lymphoma 2 (BCL2) is an antiapoptosis protein and an important clinical breast cancer prognostic marker. As the role of BCL2 is dependent on the estrogen receptor (ER) status, this effect might differ according to molecular subtypes. The aim of this study was to evaluate the relation...

Descripción completa

Detalles Bibliográficos
Autores principales: Eom, Yong Hwa, Kim, Hyung Suk, Lee, Ahwon, Song, Byung Joo, Chae, Byung Joo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053309/
https://www.ncbi.nlm.nih.gov/pubmed/27721874
http://dx.doi.org/10.4048/jbc.2016.19.3.252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053309/
https://www.ncbi.nlm.nih.gov/pubmed/27721874
http://dx.doi.org/10.4048/jbc.2016.19.3.252

Ejemplares similares